• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Introduction to Cuban-1-ylmethanamine (CAS No. 150234-60-9)

Cuban-1-ylmethanamine, a compound with the chemical identifier CAS No. 150234-60-9, represents a significant area of interest in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its unique structural framework, has garnered attention for its potential applications in the development of novel therapeutic agents. The molecular structure of Cuban-1-ylmethanamine incorporates a distinctive cubane core, which is a highly strained hydrocarbon system known for its rigidity and stability. This structural motif has been explored extensively in the design of bioactive molecules due to its ability to facilitate tight binding interactions with biological targets.

The cubane scaffold, a cubic arrangement of four carbon atoms with each carbon bonded to two other carbons and one hydrogen atom, imparts exceptional stability to the molecule. This stability is particularly advantageous in drug design, as it enhances the compound's resistance to metabolic degradation, thereby potentially increasing its bioavailability and therapeutic efficacy. The synthesis of Cuban-1-ylmethanamine involves sophisticated organic transformations that require precise control over reaction conditions to achieve high yields and purity. Advanced synthetic methodologies, including transition metal-catalyzed reactions and photochemical processes, have been employed to construct the complex cubane framework efficiently.

Recent research has highlighted the pharmacological significance of Cuban-1-ylmethanamine and related derivatives. Studies have demonstrated that compounds incorporating the cubane core exhibit remarkable binding affinity to various biological targets, including enzymes and receptors involved in critical cellular processes. For instance, derivatives of Cuban-1-ylmethanamine have shown promise in inhibiting kinases, which are pivotal in signal transduction pathways associated with cancer and inflammation. The rigid structure of these compounds allows for precise alignment with the active sites of these targets, leading to potent and selective interactions.

The exploration of Cuban-1-ylmethanamine has also led to insights into its potential role in addressing neurological disorders. Preclinical studies indicate that certain derivatives exhibit neuroprotective properties by modulating neurotransmitter systems. The unique electronic properties of the cubane core contribute to the compound's ability to interact with neurotransmitter receptors, offering a novel approach to treating conditions such as Alzheimer's disease and Parkinson's disease. These findings underscore the versatility of Cuban-based molecules in targeting diverse therapeutic areas.

In addition to its pharmacological applications, Cuban-1-ylmethanamine has been investigated for its potential in materials science. The high thermal stability and mechanical strength of cubane derivatives make them suitable candidates for advanced materials used in electronics and coatings. Researchers have explored the use of these compounds in developing high-performance polymers and liquid crystals that exhibit enhanced durability and functionality. The integration of Cuban-1-ylmethanamine into material formulations demonstrates its broad applicability beyond traditional pharmaceuticals.

The synthesis and application of Cuban-1-ylmethanamine also present challenges that drive innovation in synthetic chemistry. The construction of complex three-dimensional structures requires innovative strategies to overcome stereochemical hurdles and ensure optimal regioselectivity. Recent advancements in computational chemistry have facilitated the design of efficient synthetic routes by predicting reaction outcomes with high accuracy. These computational tools are essential for optimizing the production process and reducing costs associated with large-scale synthesis.

Ethical considerations are paramount when developing new therapeutic agents like Cuban-1-ylmethanamine. Rigorous preclinical testing is essential to evaluate safety profiles and identify potential adverse effects before human trials commence. Collaborative efforts between academic institutions, pharmaceutical companies, and regulatory agencies ensure that these compounds are developed responsibly, adhering to stringent guidelines designed to protect patient well-being.

The future prospects for Cuban-1-ylmethanamine are promising, with ongoing research aimed at expanding its therapeutic applications and improving synthetic methodologies. Innovations in drug delivery systems may further enhance the efficacy of these compounds by optimizing their bioavailability and targeting specificity. As our understanding of biological systems continues to evolve, new opportunities will emerge for leveraging the unique properties of Cuban-based molecules.

In conclusion, Cuban-1-ylmethanamine (CAS No. 150234-60-9) stands as a testament to the ingenuity of modern chemical research. Its distinctive structure offers unparalleled opportunities for designing novel therapeutic agents with significant implications for medicine and materials science. As research progresses, we can anticipate further breakthroughs that will solidify the role of Cuban derivatives as cornerstone compounds in addressing some of humanity's most pressing health challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)